MO

Moogene Medi Co., Ltd.

Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.

322970 | KO

Overview

Corporate Details

ISIN(s):
KR7322970005
LEI:
Country:
South Korea
Address:
경기도 하남시 미사강변중앙로7번안길 25씨동 10층(풍산동,유-테크밸리씨타워), 하남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Moogene Medi Co., Ltd. is a biotechnology company specializing in nano-medicine and the development of advanced drug delivery systems. The company focuses on its Lipid Nanoparticle (LNP) carrier system platform to create safer and more effective methods for transporting various therapeutic agents, such as genes, chemicals, and proteins. Moogene Medi aims to address incurable and severe diseases by developing novel therapeutics based on optimized LNPs tailored to each drug's characteristics. The company provides end-to-end support, from research and development to clinical study manufacturing in its aseptic, GMP-grade facility, also offering assay services for its developed nano-carrier systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Regulatory News Service
임상시험단계진입ㆍ종료(자율공시)
Korean 8.9 KB
2025-06-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 14.7 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 9.9 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 277.8 KB
2025-03-12 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 83.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.4 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.0 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.4 KB
2025-01-06 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-11-25 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-11-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-10-02 00:00
Regulatory News Service
기타주요경영사항(자율공시)
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all Moogene Medi Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Moogene Medi Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Moogene Medi Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Assertio Holdings, Inc. Logo
Offers branded prescription drugs for neurology, pain, and CNS to US patients.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan
4503
Astena Holdings Co., Ltd. Logo
Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.
Japan
8095
AstraZeneca PLC Logo
Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.
United Kingdom
AZN
Astria Therapeutics, Inc. Logo
Developing long-acting therapies for rare allergic and immunologic diseases like HAE.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Clinical-stage biopharma creating novel psychedelic drugs for mental health disorders.
United States of America
ATAI
Atara Biotherapeutics, Inc. Logo
Pioneering off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ATRA
Atea Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing oral antiviral therapies for viruses like Hepatitis C.
United States of America
AVIR
Athira Pharma, Inc. Logo
Developing small-molecule therapies to slow neurodegeneration in diseases like Alzheimer's.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing (Z)-endoxifen for breast cancer treatment and prevention.
United States of America
ATOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.